Knight Cancer clinicians at Tuality/OHSU Cancer Center are the first in Oregon to offer a treatment option that will improve outcomes for patients with bladder cancer who cannot tolerate surgery or...
When chemotherapy stops working and stem-cell transplantation fails or is not an option, medicine has little to offer patients with the aggressive blood cancer called diffuse large B-cell lymphoma,...
Cancer researchers at OHSU have been awarded $1 million to test the idea that adjusting the diversity of bacteria inhabiting the intestines could make aggressive prostate cancers more responsive to...
Scrutinizing the immune cells infiltrating a tumor may reveal the cancer's vulnerability or resistance to immune-based therapies. Cancer immune therapies have delivered life-saving, long-lasting...